Document is current
Any future updates will be listed below
-
Authors
Ilyasova, Anna A.
Kim, Edwin H.
- License Information
-
More Information
Article History
Received: 3 September 2025
Accepted: 9 December 2025
First Online: 3 January 2026
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: E.K. reports consultancy fees from ALK, Allergy Therapeutics, Cellergy Pharma, DBV Technologies, Genentech, Hanimune Therapeutics, IgGenix, Phylaxis BioScience, Revolo Biotherapeutics, Ukko; grants to his university from NIH-NIAID, Food Allergy Research and Education (FARE). A.I. reports no conflicts of interest.
